EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Quantitative MRI tenosynovitis volume explains the association between tendon involvement and future development of clinical arthritis in anti-cyclic citrullinated peptide-positive at-risk individuals

Kerem Abacar, Yuya Tabuchi, Andrea Di Matteo, Laurence Duquenne, Emma Rowbotham, Jacqueline Nam, Paul Emery, Dennis McGonagle, Kulveer Mankia

Annals of the Rheumatic Diseases · 2026

DOI: 10.1016/j.ard.2025.10.020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of the Rheumatic Diseases, 2026. Verfasst von Kerem Abacar und 8 weiteren Autor:innen. Beteiligte Einrichtung: University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine, Leeds, UK. Hauptthemen laut MEDLINE: Tenosynovitis, Anti-Citrullinated Protein Antibodies, Arthritis, Rheumatoid, Tendons. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Leeds Biomedical Research Centre, NIHR Imperial Biomedical Research Centre, National Institute for Health and Care Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Tenosynovitis is a key imaging feature in the preclinical phase of rheumatoid arthritis. Prior studies suggest that presence of magnetic resonance imaging (MRI) tenosynovitis may better predict future clinical arthritis than MRI synovitis. We hypothesised that the volume of subclinical inflammation within tendon sheaths may explain this association in anti-cyclic citrullinated peptide (anti-CCP) positive at-risk individuals. This study sought to assess whether MRI-derived tenosynovitis (TSV) and joint synovitis (SV) volumes predict inflammatory arthritis (IA) in anti-CCP-positive individuals without clinical synovitis, beyond clinical/serological markers. METHODS: We included 223 anti-CCP-positive individuals with musculoskeletal symptoms without clinical synovitis. All underwent baseline contrast-enhanced MRI of the hand and wrist. TSV and SV were quantified via manual segmentation and three-dimensional (3D) reconstruction (OsiriX-MD). IA progression was defined as ≥1 clinically swollen joint. Cox regression and receiver operating characteristic (ROC) analyses were performed. RESULTS: Of 223 participants, 67 (30%) developed IA over a median 13.3-month follow-up. Inter-reader agreement for volumetric scoring was excellent (intraclass correlation coefficient > 0.90 across all regions). Baseline tenosynovitis (34.5%) was associated with progression (P < .001). TSV was higher in progressors than non-progressors (1607 vs 705 mm³, P = .003), remained predictive after adjusting for SV (P = .008), and outperformed SV in ROC analysis (area under curve (AUC) = 0.697 vs 0.582). In multivariable analysis, TSV (P < .001) and tender joint count (P = .014) independently predicted progression beyond clinical and serological markers. Higher total inflammation volume correlated with shorter time to progression (P = .008). CONCLUSIONS: MRI-derived TSV independently predicts IA and outperforms SV. Quantitative TSV assessment may enhance risk stratification and support preventive strategies in at-risk individuals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TenosynovitisAnti-Citrullinated Protein AntibodiesArthritis, RheumatoidTendonsHumansFemaleMagnetic Resonance ImagingMaleMiddle AgedDisease ProgressionSynovitisAdultAgedBiomarkersWrist Joint

Substanzen

Anti-Citrullinated Protein AntibodiesBiomarkers

Autor:innen und Institutionen

  • University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine, Leeds, UK.
  • University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine, Leeds, UK; Kyoto University, Graduate School of Medicine, Department of Rheumatology and Clinical Immunology, Kyoto, Japan.
  • University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine, Leeds, UK; NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Chapel Allerton Hospital, Leeds, UK.
  • National Institute for Health Research Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK; Department of Musculoskeletal Radiology, Leeds Teaching Hospitals, Leeds, UK.
  • NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Chapel Allerton Hospital, Leeds, UK.
  • University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine, Leeds, UK; NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Chapel Allerton Hospital, Leeds, UK. Electronic addre…

Förderung

  • Leeds Biomedical Research Centre
  • NIHR Imperial Biomedical Research Centre
  • National Institute for Health and Care Research

Zitieren

APA

Abacar, K., Tabuchi, Y., Di Matteo, A., Duquenne, L., Rowbotham, E., Nam, J., Emery, P., McGonagle, D., & Mankia, K. (2026). Quantitative MRI tenosynovitis volume explains the association between tendon involvement and future development of clinical arthritis in anti-cyclic citrullinated peptide-positive at-risk individuals. Annals of the Rheumatic Diseases. https://doi.org/10.1016/j.ard.2025.10.020

Vancouver

Abacar K, Tabuchi Y, Di Matteo A, Duquenne L, Rowbotham E, Nam J, et al. Quantitative MRI tenosynovitis volume explains the association between tendon involvement and future development of clinical arthritis in anti-cyclic citrullinated peptide-positive at-risk individuals. Annals of the Rheumatic Diseases. 2026. doi:10.1016/j.ard.2025.10.020

BibTeX
@article{Abacar2026,
  author = {Abacar, Kerem and Tabuchi, Yuya and Di Matteo, Andrea and Duquenne, Laurence and Rowbotham, Emma and Nam, Jacqueline and Emery, Paul and McGonagle, Dennis and Mankia, Kulveer},
  title = {Quantitative MRI tenosynovitis volume explains the association between tendon involvement and future development of clinical arthritis in anti-cyclic citrullinated peptide-positive at-risk individuals},
  journal = {Annals of the Rheumatic Diseases},
  year = {2026},
  doi = {10.1016/j.ard.2025.10.020}
}
Kostenlos starten →